Sonuç olarak çalıĢmamızda MS‟li hastalarla kontrol grubu karĢılaĢtırıldığında yaĢ, cinsiyet, eğitim düzeyi ve depresyon bakımından herhangi bir farklılık olmadığı görülmüĢtür.
Hastalar arasında cinsiyet bakımından kıyas yapıldığında ise erkek hastaların PASAT ve SDMT „de daha yüksek puan aldıkları görülmüĢtür. ÇalıĢmamızda hasta grubunda hastalık süresi, PASAT, SDMT, Bender Gestalt Testi-Süre ve Bender Gestalt Testi-Hata sonuçlarının birbirleriyle iliĢkisine bakıldı. PASAT ve SDMT arasında doğru orantılı istatistiksel olarak anlamlı iliĢki bulundu. Yani hastaların PASAT puanı arttıkça SDMT puanı da artmaktadır.
Bender Gestalt Testi-Süre ve Bender Gestalt Testi-Hata arasında ise doğru orantılı, istatistiksel olarak anlamlı iliĢki bulundu. Bender Gestalt Testi‟ni daha kısa sürede tamamlayan hastaların daha az hata puanına sahip olduğu ve aynı Ģekilde bu testi uzun sürede tamamlayanların daha fazla hata puanına sahip oldukları görülmüĢtür. SDMT ile Bender Gestalt Testi-Süre arasında ters orantılı, istatistiksel olarak anlamlı iliĢki bulundu. SDMT ile Bender Gestalt Testi-Hata arasında ise ters orantılı istatistiksel olarak anlamlı iliĢki bulundu.
Bu sonuca göre hastalar SDMT‟de yüksek puan aldıkça, Bender Gestalt Testi‟ni daha kısa sürede ve hata puanı düĢük olarak tamamladığı görülmüĢtür. Bender Gestalt Testi literatürde MS hastalarının kognitif değerlendirmesinde bildiğimiz kadarıyla ilk kez kullanılmıĢ olup, daha önce yaygın bir Ģekilde tüm dünyada kullanılan SDMT ile arasında istatistiksel olarak anlamlı iliĢki bulunması çalıĢmamızı diğer çalıĢmalardan farklı kılmaktadır. Fakat Bender Gestalt Testi‟nin MS‟li hastaların kognitif fonksiyonlarını değerlendirmesinde kullanılabilmesi için daha geniĢ popülasyonla yapılan çalıĢmalara ihtiyaç olduğu düĢünmekteyiz.
31
KAYNAKLAR
1- Ropper AH, Brown RH. Adams and Victor‟s Principles of Neurology. Emre M (Çeviren) Ankara, GüneĢ Kitabevi, 2006, 771-97
2- Eraksoy M, Akman DG. Merkez sinir sisteminin miyelin hastalıkları. A. Emre ÖGE (editör). Ġstanbul Tıp Fakültesi Temel ve Klinik Bilimler Ders Kitapları. Nöroloji. Ġstanbul:
Nobel Kitabevi, 2004, 505-35
3- Ġdiman E. Demyelinizan hastalıklar: Oğul E. (Ed), Klinik Nöroloji, Nobel GüneĢ Yayınevi, 2002, 159-85
4- Vukusic S, Confavreux C. The natural history of multiple sclerosis. Cook SD, ed.
Handbook of multiple sclerosis. 3rd ed. New York: Marcel Dekker, 2001, 433–47 5- Yüceyar N, Sağduyu A. Multıpl skleroz‟da tanı kriterleri. Türkiye Klinikleri Nöroloji Dergisi, 2009, 2: 22-29
6- Nazlıel B. Multiple Sklerozda Etyopatogenez. In: KarakaĢ S. Kognitif Nörobilimler. 2.
Baskı: Nobel Tıp Kitap Sarayı, 2008, 630-1
7- Hahnel S. Ġnflammatory Diseases of the Brain. 2009, Springer
8- Lublin FD, Miller Aaron E. (Çeviri; Kurne A.) Multiple Skleroz ve Santral Sinir Sisteminin Diğer Demyelinizan Hastalıkları. In: Bradley W.G., Daroff R.B., Fenichel G.M., Jankovic J.Neurology in Clinical Practice. 5. Baskı: Medikal Yayıncılık, 2008, 1590
9- Hemmer B, Cepok S, Nessler S, Sommer N. Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 2002, 15: 227-31
10- Miller AE, Lublin FD, Coyle PK (editors). Epidemiology and genetics. Multiple Sclerosis in Clinical Practice. 2 ed. London: Martin Dunitz 2003, 31-33
11- Ġdiman E. Multipl skleroz‟un immunopatogenezi. Türkiye Klinikleri Nöroloji Multipl Skleroz Özel Sayısı 2004, 2: 171-6
12- Eraksoy M, Akman-Demir G. Merkezi Sinir Sisteminin Myelin Hastalıkları. In: Öge A.E., Baykan B. Nöroloji .2.Baskı: Nobel Tıp Kitabevi, 2011, 603-29
32 13- Ġdiman F. Multipl sklerozda uyarılmıĢ potansiyeller. Türkiye Klinikleri Nöroloji Dergisi 2004, 2: 161-256
14- Bradley WG, Daroff RB, Fenichel GM, Marsden CD (edit), Francis GS, Duquette P, Antel JP. Neurolgy in Clinical Practice, Ġnflammatory Demyelinating Diseases of the Central Nervous System. 2. Baskı, Boston: Buttrworth Heinemann 1995, 1324-7
15- Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato I, Fredman P, Frederiksen J, et al.
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol 1994, 57: 897-902
16- Adams RD, Victor M, Ropper AH. In “Principles of Neurology”, Multiple Sclerosis and Allied Demyelinative Diseases. Part 4, 36. 6th. New York: McGraw- Hill. 1997, 908-10 17- Ropper AH, Brown RH. Multiple sclerosis and allied demyelinative diseases. Adams and Victor's principles of neurology, 8th ed. New York: McGraw Hill Co 2005, 771-96
18- McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann.
Neurol.2001, 50 (1): 121–7
19- Polman CH, Reingold SC, Edan G et al. "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology. 2005, 58 (6): 840–6
20- Polman, Chris et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Annals of Neurology 2011, 69 (2): 292–302
21- Kraft GH, Cui JY. Multiple sclerosis. In: De Lisa JA (Ed). Physical medicine and rehabilitation principles and practice. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2005, 1753-69
22- Confavreux C, Compston A. The natural history of multiple sclerosis. In: Compston A (Ed). McAlpine‟s multiple sclerosis. 4th ed. Philadelphia: Churchill Livingstone Elsevier, 2006, 183-272
23- Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, Ricchiuti L, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 2006, 253: 1054-9
33 24- Koçer B, Ġrkeç C. Multiple Sklerozda Kognitif Bozukluklar ve Tedavisi. In: KarakaĢ S.
Kognitif Nörobilimler. 2. Baskı: Nobel Tıp Kitap Sarayı, 2008, 638-48
25- McDonald IR, Compston A. The symptoms and signs of multiple sclerosis. In: Compston A, Confavreux C, Lassmann H, McDonald IR, Miller DH, Noseworthy J, Smith KJ, Wekerle H; editors. Mc Alpine‟s Multiple Sclerosis. 4 th Edition. Churchill Livingstone Elsevier, 2006, 191-221
26- R, Kremenchutzky M, Rice GPA: The naturel history of multiple sclerosis.In: Freedman MS ed. Multiple sclerosis and demyelinating diseases.Avences in Neurology Volume 98.
Philadelphia:Lippincott Williams Wilkins 2006, 1-15
27- Gilroy J. In Basic Neurology. 3rd ed. McGraw-Hill, New York, St. Louis. 2000, 199-223 28- Thompson AJ, Kermode AG, Moseley IF, MacManus DG, McDonald WI. Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol 1993, 56: 1317-20
29- Lucas K, Houhlfeld R. Tolerance and Autoimmune Disease. New ingishts on immunological Tolerance Mechanisms. The International MS Journal 2000, 7: 41-50
30- Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand 2005, 112: 463-8
31- Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Arch Neurol 1990, 47:
98-104
32- Skegg K, Corwin PA, Skegg DC. How often is MS mistaken for a psychiatric disorder.
Psyc Med 1988, 18: 733-6
33- Tuncer N. Multipl Sklerozlu Olgularda Kognitif Fonksiyon Bozuklukları. Türkiye Klinikleri 2006, 26: 559-64
34- Lynch, SG, Parmenter, BA, Denney, DR. The association between cognitive impairment and physical disability in multiple sclerosis. Multiple Sclerosis 2005, 11: 469–76
35- Rogers, JM, Panegyres, PK. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. Journal of Clinical Neuroscience 2007, 14: 919–27
34 36- Winkelmann A, Engel C, Apel A. Cognitive impairment in multiple sclerozis. J Neurol 2008, 255: 309-10
37- Ellger T, Bethke F, Frese A, Luettmann RJ, Buchheister A, Ringelstein EB and Evers S.
Event-related potentials in different subtypes of multiple sclerosis: A cross-sectional study. J Neurol Sci 2002, 205: 35-40
38- Foong J, Rosewich L, Qaghebeur G, Thompson AJ, Miller DH, Ron MA.
Neuropsychological deficits in multiple sclerosisafter acute relapse. J Neurol 1998, 64: 529-32
39- Catalaa I, Fulton JC, Zhang X, et al. MR imaging quantitation of gray matter involvement in multiple sclerosis and its correlation with disability measures and neurocognitive testing.
AJNR American Journal of Neuroradiology 1999, 20: 1613– 8
40- Amato, MP, Ponziani, G, Siracusa, G, Sorbi, S. Cognitive dysfunction in earlyonset multiple sclerosis: a reappraisal after 10 years. Archives of Neurology 2001, 58: 1602–6 41- Rao SM, Leo GJ, Ellington L, et al. Cognitive dysfunction in multiple sclerosis II: Impact on employment and social functioning. Neurology 1991, 41: 692–6
42- Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis.
Neuropsychology Review 1998, 8: 43–77
43- Comi G, Filippi M, Martinelli V, Campi A, Rodegher M, Alberoni M, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995, 132: 222–7
44- Amato MP, Zipoli V, Portaccio E. Cognitive changes in multiple sclerosis. Expert Review of Neurotherapeutics 2008, 8: 1585-96
45- Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R, Farina D.
Gender-related affect of clinical and genetic variables on the cognitive impairment in ultiple sclerosis. Journal of Neurology 2004, 251 (10): 1208-14
46- Ron MA, Callanan MM, Warrington EK. Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study. Psychological Medicine 1991, 21(1): 59-68
35 47- Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and
patterns of cognitive impairment in multiple sclerosis. Neurology 1998, 50: 1601– 8
48- Rovaris M, Iannucci G,Falautano M, Possa F. Martinelli V, Comi G, Filippi M, Cognitive dysfunction in patients with mildly disabling relapsing– remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. Journal of the Neurological Sciences 2002, 195: 103– 9
49- Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003, 16: 283-8
50- Bagert B, Camplair P, Bourdette D. Cognitive dysfunction in multiple sclerosis. Natural history, Pathophysiology and Management. CNS Drugs 2002, 16: 445-55
51- Litvan I, Grafman J, Vendrell P, Martinez JM, Junqué C, Vendrell JM, et al. Multiple memory deficits in multiple sclerosis: exploring the working memory system. Arch Neurol 1988, 45: 607-10
52- Foong J, Rozewicz L, Quaghebeur G, Davie CA, Kartsounis LD, Thompson AJ, et al.
Executive function in multiple sclerosis: the role of frontal lobe pathology. Brain 1997, 120:
15-26
53- Zarei M, Chandran S, Compston A, Hodges J, Cognitive presentation of multiple sclerosis: Evidence for acortical variant. J Neurol 2003, 74: 872-7
54- Ge Y, Grossman RI, Udupa JK, Bab JS, Kolson DL, McGowan JC. Magnetization transver ratio histogram analysis of gray matter in relapsingremittig multiple sclerosis. AJNR Am J Neuroradiol 2001, 22: 470-5
55- Van Buchem MA, Grossman RI, Armstrong C, Polansky M, Miki Y, Heyning FH, et al.
Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998, 50: 1609-17
56- Benedict R, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: Comparision of conventional
magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004, 61:
226-30
36 57- Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988, 45: 435-7
58- Paulesu E, Perani D, Fazio F, Comi G, Pozzilli C, Martinelli V, et al. Functional basis of memory impairment in multiple sclerosis: A[18F]FDG PET study. Neuroimage 1996, 4: 87-96
59- Rao SM. Neuropsycology of multiple sclerozis. Curr Opin Neurol 1995, 8: 216-20 60- Elliott R. The neuropsychological profile in unipolar depression. Trends Cogn Sci 1998, 2: 447-54
61- Arnett PA, Higginson CI, Voss WD, Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. J Clin Neuropsyc 1999, 13: 434-46 62- McCabe MP, McKern S, McDonald E. Coping and psycholojical adjustment among people with multiple sclerosis. J Psychosom Res; 2004, 56: 355-61
63- Aksoy, S., Timer, E., Mumcu, S., Akgün, M., Kıvrak, E. ve Necioğlu-Örken, D. Multipl Sklerozda BiliĢsel Etkilenmenin MOBĠD Ölçeği Ġle Taranması. Türk Nöroloji Dergisi 2013, 19: 52-55
64- ÖzakbaĢ, S. Multipl Sklerozda Semptomatik Tedavi. Nöropsikiyatri Arşivi 2011, 48 (2):
83-89
65- Leo GJ, Rao SM. Effects of intravenous physostigmine and lecithine on memory in multiple sclerosis: Report of a pilot study. J Neurol Reh 1988, 2: 123-9
66- Unverzagt FW, Rao SM, Antuono PG. Oral physostigmine in the treatment of memory loss in multiple sclerosis. J Clin Neuropsyc 1991, 13: 74
67- Greene YM, Tariot PN, Wishart H. A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psych 2000, 20:
350-6
68- Krupp LB, Christodoulou C, Melville P, Scherl WF, MacAllister WS, Elkins LE.
Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004, 63: 1579-85
37 69- Krupp, LB., Christodoulou, C., Melville, P., Scherl, WF., Pai, LY., Muenz, LR., Benedict, RHB., Goodman, A., Rizvi, S., Schwid, SR., Weinstock-Guttman, B., Westervelt, HJ. ve Wishart, H. Multicenter Randomized Clinical Trial Of Donepezil For Memory Impairment In Multiple Sclerosis. Neurology 2011, 76 (17): 1500-7
70- Rubin, SM. Management Of Cognition And Fatigue. Disease-a-Month 2013, 59: 269-72 71- Birnboim S, Miller A. Cognitive strategies application of multiple sclerosis patients.
Multiple Sklerosis Journal 2004, 10 (1): 67-73
72- Chiaravalloti, ND. DeLuca, J., Moore, NB. ve Ricker, JH. Treating Learning Impairments Improves Memory Performance In Multiple Sclerosis: A Randomized Clinical Trial. Multiple Sclerosis 2005, 11(1): 58-68
73- Güçlü-Altun, Ġ., KırbaĢ, D., Altun, DU., Soysal, A., SütlaĢ, PN., Yandım-KuĢçu, D., Behrem-Gayır, N., Arslan, E., Topçular, B. Relaps Ve Remisyonlarla Seyreden Multipl Skleroz Olgularında BiliĢsel Rehabilitasyonun Etkileri. Nöropsikiyatri ArĢivi 2015, 52: 174-9 74- Wallin, MT., Wilken, JA., Kane, R. Cognitive Dysfunction In Multiple Sclerosis:
Assessment, Imaging And Risk Factors. Journal of Rehabilitation Research & Development 2006, 43(1): 63-72
75- Benedict, RH., Fischer, JS., Archibald, CJ., Arnett, PA., Beatty, WW., Bobholz, J., Chelune, GJ., Fisk, JD., Longdon, DW., Caruso, L., Foley, F., LaRocca, NG., Volwes, L., Weinstein, A., DeLuca, J., Rao, SM. ve Munschauer, F. Minimal Neuropsychology
Assessment Of MMS Patients: A Consensus Approach. The Clinical Neuropsychologist 2002, 16 (3): 381-97
76- Portaccio, E., Stromillo, ML., Goretti, B., Zipoli, V., Siracusa, G., Battaglini, M., Giorgio, A., Bartolozzi, ML., Guidi, L.,Sorbi, S., Federico, A., Amato, MP., De Stefano, N.
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology 2009, 73: 498-503
77- Langdon, DW. Amato, MP., Boringa, J., Brochet, B., Foley, F., Frederikson, S., Hamalainen, P., Hartung, HP., Krupp, L., Penner, IK., Reder, AT. ve Benedict, RH.
Recommendations For A Brief International Cognitive Assessment For Multiple Sclerosis (BICAMS). Multipl Sclerosis 2012, 18: 891-8
38 78- 109- Wilken, JA., Kane, R., Sullivan, CL., Wallin, M., Usiskin, JB., Quig, ME.,
Simsarian, J., Saunders, C., Crayton, H., Mandler, R., Kerr, D., Reeves, D., Fuchs, K.,
Manning, C. ve Keller, M. The Utulity Of Computerized Neuropsychological Assessment Of Cognitive Dysfunction In Patients With Relapsing-Remitting Multipl Sclerosis. Multipl Sclerosis 2003, 9 (2): 119-27
79- Rao SM. A manual for the brief, repeatable battery of neuropsychological tests in multiple sclerosis. Cognitive Function Study Group, National Multiple Schlerosis Society 1991
80- Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE, et al.
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire. Mult Scler 2008, 14: 940-6
81- Bender, L: A visual-motor Gestalt test and its clinical use. Amercan Orthopsychiatric Association Monograph Series Number 3. New York: American Orthopsychiatric Association 1938,
82- Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Multiple Sclerosis 2003, 9:
393-6
83- Feinstein A, Feinstein K. Depression Associated With Multiple Sklerosis Looking Beyond Diagnosis to Symptom Expression. J Affect Disord 2001, 66: 193-8
84- Aikens JE, Reinecke MA, Pliskin NH, Fischer JS, Wiebe JS, McCracken LM, Taylor JL.
Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory Behav Med 1999, 22: 127-42
85- 119- Soyuer F, Ünalan D, Mirza M. MS‟te Depresif Semptomlar. Turk Nöroloji Dergisi 2010, 16: 31-35
86- Emine Bilgi, Hasan Hüseyin Özdemir, Serpil Bulut. Determining the Frequency of Depression and Cognitive Dysfunction in Patients with Multiple Sclerosis. Turk J Neurol. 2013 19 (1): 11-14
39 87- Portaccio E, Goretti B, Zipoli V, Siracusa G, Sorbi S, and Amato MP. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuro 2009, 23: 268-75
88- Muriel Laffon, Grégoire Malandain, Heloise Joly, Mikael Cohen, and Christine Lebrun.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice. Neurol Ther. 2014, 3(2): 113–22
89- Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment.
National MS society clinical outcomes assessment task force. Mult Scler. 1999, 5: 244–50 90- Smith A. Symbol Digit Modalities Test: Manual. Los Angeles: Western Psychologial Services, 1982.
91- López-Góngora M, Querol L, Escartin A. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. BMC Neurology 2015, 15: 40
92- Dalos NP, Rabins PV, Brooks BR, O‟Donnell P. Disease Activity And Emotional satate in multiple sklerosis. Ann Neurol 1983, 13: 573-7
40
EKLER
EK.1. ÖZGEÇMĠġ A. KĠġĠSEL BĠLGĠLER
Adı soyadı: Yasemin DEMĠRTAġ
Doğum tarihi ve yeri: 26-11-1988 / MALATYA Yabancı dil bilgisi: Ġngilizce – YÖKDĠL (70)
Görev yeri: Ġnönü Üniversitesi TÖTM Nöroloji AD, Malatya
ĠletiĢim bilgileri (e-posta / telefon): ysmndmrts@yahoo.com / 05548481142
B. EĞĠTĠM BĠLGĠLERĠ
Mezun olduğu üniversite/fakülte: Ġstanbul Üniversitesi / Edebiyat Fakültesi Mezuniyet tarihi (yıl olarak): 2010
Varsa, akademik unvan (lar):
C. Ġġ TECRÜBESĠNE AĠT BĠLGĠLER